Levels of lectin pathway proteins in plasma and synovial Xuid of rheumatoid arthritis and osteoarthritis

Rheumatology International

Volumn 32, Issue 5, 2012, Pages 1457-1463

  Ammitzboll, C G ^a   Thiel, S ^b   Ellingsen, T ^a   Deleuran, B ^a   Jorgensen, Anette ^a   Jensenius, J C ^b   Stengaard Pedersen, K ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c SILKEBORG REGIONAL HOSPITAL   (Denmark)

Author keywords

Ficolin; Mannose binding lectin; MBL associated serine protease; Osteoarthritis; Rheumatoid arthritis; Synovial Xuid

Indexed keywords

FICOLIN; MANNAN BINDING LECTIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 2; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIAL FLUID LEVEL;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COMPLEMENT SYSTEM PROTEINS; DENMARK; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNITY, INNATE; LECTINS; MALE; MANNOSE-BINDING LECTIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MIDDLE AGED; NEUTROPHILS; OSTEOARTHRITIS; SYNOVIAL FLUID;

EID: 84863634552     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1879-x     Document Type: Article

References (24)

1. Thiel S, Gadjeva M (2009) Humoral pattern recognition molecules: mannan-binding lectin and Wcolins. Adv Exp Med Biol 653:58-73
2. Walport MJ (2001) Complement. First of two parts. N Engl J Med 344:1058-1066
3. Okroj M, Heinegård D, Holmdahl R, Blom AM (2007) Rheumatoid arthritis and the complement system. Ann Med 39:517-530
4. Wang Y, Rollins SA, Madri JA, Matis LA (1995) Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc Natl Acad Sci USA 92:8955-8959
5. Makinde VA, Senaldi G, Jawad AS, Berry H, Vergani D (1989) ReXection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway. Ann Rheum Dis 48:302-306
6. Brodeur JP, Ruddy S, Schwartz LB, Moxley G (1991) Synovial Xuid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis. Arthritis Rheum 34:1531-1537
7. Cooke TD, Richer S, Hurd E, Jasin HE (1975) Localization of antigen-antibody complexes in intraarticular collagenous tissues. Ann NY Acad Sci 256:10-24
8. Konttinen YT, Ceponis A, Meri S, Vuorikoski A, Kortekangas P, Sorsa T, Sukura A, Santavirta S (1996) Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane. Ann Rheum Dis 55:888-894
9. John T, Stahel PF, Morgan SJ, Schulze-Tanzil G (2007) Impact of the complement cascade on posttraumatic cartilage inXammation and degradation. Histol Histopathol 22:781-790
10. Graudal N (2004) The natural history and prognosis of rheumatoid arthritis: association of radiographic outcome with process variables, joint motion and immune proteins. Scand J Rheumatol 33(118):1-37
11. Jacobsen S, Garred P, Madsen HO et al (2009) Mannose-binding lectin gene polymorphisms are associated with disease activity and physical disability in untreated, anti-cyclic citrullinated peptide-positive patients with early rheumatoid arthritis. J Rheumatol 36:731-735
12. Vander CB, Nuytinck L, Boullart L et al (2007) Polymorphisms in the Wcolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis. Rheumatology (Oxford) 46:1792-1795
13. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB (1995) Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1:237-243
14. Jorgensen A, Stengaard-Pedersen K, Simonsen O et al (2010) Intra-articular hyaluronan is without clinical eVect in knee osteo-arthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year. Ann Rheum Dis 69:1097-1102
15. Gadjeva M, Thiel S, Jensenius JC (2004) Assays for the mannan-binding lectin pathway. Curr Protoc Immunol Chapter 13:Unit
16. Moller-Kristensen M, Jensenius JC, Jensen L, Thielens N, Rossi V, Arlaud G, Thiel S (2003) Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals. J Immunol Methods 282:159-167
17. Schlapbach LJ, Mattmann M, Thiel S, Boillat C, Otth M, Nelle M, Wagner B, Jensenius JC, Aebi C (2010) DiVerential role of the lec-tin pathway of complement activation in susceptibility to neonatal sepsis. Clin Infect Dis 51:153-162
18. Wittenborn T, Thiel S, Jensen L, Nielsen HJ, Jensenius JC (2010) Characteristics and biological variations of M-Wcolin, a pattern recognition molecule, in plasma. J Innate Immun 2:167-180
19. Krarup A, Sorensen UB, Matsushita M, Jensenius JC, Thiel S (2005) EVect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-Wcolin, and H-Wcolin. Infect Immun 73:1052-1060
20. Swaak AJ, Van RA, Planten O, Han H, Hattink O, Hack E (1987) An analysis of the levels of complement components in the syno-vial Xuid in rheumatic diseases. Clin Rheumatol 6:350-357
21. Saevarsdottir S, Steinsson K, Grondal G, Valdimarsson H (2007) Patients with rheumatoid arthritis have higher levels of mannan-binding lectin than their Wrst-degree relatives and unrelated controls. J Rheumatol 34:1692-1695
22. Ytting H, Christensen IJ, Thiel S, Jensenius JC, Svendsen MN, Nielsen L, Lottenburger T, Nielsen HJ (2007) Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the inXuence of age, gender and physical exercise. Scand J Immunol 66:458-464
23. Liu Y, Endo Y, Iwaki D, Nakata M, Matsushita M, Wada I, Inoue K, Munakata M, Fujita T (2005) Human M-Wcolin is a secretory protein that activates the lectin complement pathway. J Immunol 175:3150-3156
24. Theilgaard-Monch K, Jacobsen LC, Borup R, Rasmussen T, Bjer-regaard MD, Nielsen FC, Cowland JB, Borregaard N (2005) The transcriptional program of terminal granulocytic diVerentiation. Blood 105:1785-1796